Special Issue "Nanomaterials for In Vivo Imaging and Theranostics"

A special issue of Materials (ISSN 1996-1944). This special issue belongs to the section "Advanced Nanomaterials and Nanotechnology".

Deadline for manuscript submissions: 30 November 2020.

Special Issue Editor

Prof. Hyung-Jun Im
Website
Guest Editor
Department of Transdisciplinary Studies, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea
Interests: radionanomedicine; theranostics; molecular imaging

Special Issue Information

Dear Colleagues,

In vivo imaging enables us to monitor the whereabouts of contrast agents and characterize and quantify the biochemical phenomena in the living subjects non-invasively. It has become an indispensable tool for life science and medical research, and some of the new contrast agents for in vivo imaging have been translated into the clinic. Nanomaterials have advantages over conventional small molecule-based contrast agents, which include the feasibility of surface modification for optimized biodistribution and multifunctionalization for multimodal imaging. Further, in vivo imaging is an essential tool for the development of nanomedicine because it can provide information regarding biodistribution and the excretion pattern of nanomaterials. Furthermore, nanomaterials for in vivo imaging can be loaded with therapeutic agents and become theranostic nanomedicine. In vivo imaging can be utilized for the precise selection of the subjects which will respond to theranostic nanomedicine.

In this Special Issue, recent developments in in vivo imaging methods, synthesis of nanomaterials for contrast agents, applications of nanomaterials for in vivo imaging, and theranostics in various disease models will be highlighted and discussed.

It is my pleasure to invite you to submit a manuscript for this Special Issue. Full papers, communications, and reviews are all welcome.

Prof. Hyung-Jun Im
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Materials is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Nanomaterials
  • In vivo imaging
  • Nanomedicine
  • Molecular imaging
  • Radionanomedicine
  • Magnetic resonance imaging
  • Ultrasound imaging
  • Optical imaging
  • Photoacoustic imaging
  • X-ray fluorescence computed tomography
  • Theranostics
  • Companion diagnostics
  • Precision medicine

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Open AccessArticle
Antitumor Efficacy of Focused Ultrasound-MFL Nanoparticles Combination Therapy in Mouse Breast Cancer Xenografts
Materials 2020, 13(5), 1099; https://doi.org/10.3390/ma13051099 - 02 Mar 2020
Abstract
High doses of chemotherapy agents can cause adverse effects. To address this issue, drug-loaded vesicles with minimum drug loss, guided by an external element for precise delivery, are desired. Combinational therapy of both a focused ultrasound-induced drug delivery method and membrane fusogenic liposomes [...] Read more.
High doses of chemotherapy agents can cause adverse effects. To address this issue, drug-loaded vesicles with minimum drug loss, guided by an external element for precise delivery, are desired. Combinational therapy of both a focused ultrasound-induced drug delivery method and membrane fusogenic liposomes (MFLs) as drug delivery vehicles can satisfy such premises. In this study, we confirmed that the use of a small quantity of docetaxel-loaded membrane fusogenic liposomes (DTX-MFL) with focused ultrasound can induce better antitumor response in a xenograft mouse model compared to conventional docetaxel monotherapy and DTX-MFL only. Full article
(This article belongs to the Special Issue Nanomaterials for In Vivo Imaging and Theranostics)
Show Figures

Figure 1

Back to TopTop